- Home
- GRAL vs VINP Comparison
GRAL vs VINP Comparison
Compare GRAL & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRAL
- VINP
- Stock Information
- Founded
- GRAL 2016
- VINP 2009
- Country
- GRAL United States
- VINP Brazil
- Employees
- GRAL N/A
- VINP N/A
- Industry
- GRAL
- VINP Investment Managers
- Sector
- GRAL
- VINP Finance
- Exchange
- GRAL NYSE
- VINP Nasdaq
- Market Cap
- GRAL 1.3B
- VINP 593.2M
- IPO Year
- GRAL N/A
- VINP 2021
- Fundamental
- Price
- GRAL $46.72
- VINP $9.77
- Analyst Decision
- GRAL Buy
- VINP Strong Buy
- Analyst Count
- GRAL 3
- VINP 2
- Target Price
- GRAL $31.50
- VINP $13.25
- AVG Volume (30 Days)
- GRAL 1.6M
- VINP 55.8K
- Earning Date
- GRAL 08-12-2025
- VINP 08-06-2025
- Dividend Yield
- GRAL N/A
- VINP 6.65%
- EPS Growth
- GRAL N/A
- VINP N/A
- EPS
- GRAL N/A
- VINP 0.38
- Revenue
- GRAL $130,711,000.00
- VINP $126,696,258.00
- Revenue This Year
- GRAL $19.52
- VINP $70.28
- Revenue Next Year
- GRAL $20.37
- VINP $14.37
- P/E Ratio
- GRAL N/A
- VINP $25.66
- Revenue Growth
- GRAL 30.47
- VINP 57.51
- 52 Week Low
- GRAL $12.33
- VINP $8.66
- 52 Week High
- GRAL $63.99
- VINP $11.62
- Technical
- Relative Strength Index (RSI)
- GRAL N/A
- VINP 54.87
- Support Level
- GRAL N/A
- VINP $9.43
- Resistance Level
- GRAL N/A
- VINP $9.94
- Average True Range (ATR)
- GRAL 0.00
- VINP 0.25
- MACD
- GRAL 0.00
- VINP 0.03
- Stochastic Oscillator
- GRAL 0.00
- VINP 70.65
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
About VINP Vinci Partners Investments Ltd.
Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Equity, Equities, Real Assets, Credit, Global IP&S, and Corporate Advisory. The company's majority of its revenue comes from the Private Equity segment, which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.